July 3, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of Philips’ Executive Committee, reporting to Philips CEO Roy Jakobs. She succeeds Andy [...]
Baar, Switzerland, 2 July 2024 Ascom and Almaviva, an Italian leading information and communication technology company, have entered a strategic partnership to drive the digital transformation of the Italian healthcare sector. As part of this partnership, Ascom has been commissioned with significant Digistat projects for patient data management, including professional services and software. Further projects are [...]
Mr. Oliveira is an accomplished biopharmaceutical industry executive with nearly 25 years of commercial experience, building high-performing teams, and launching multiple successful pharmaceutical products WALTHAM, Mass., July 01, 2024 (Korea Bizwire) – Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based therapies, today announced the appointment [...]
RIYADH, Saudi Arabia, July 01, 2024 (Korea Bizwire) – King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed 5,000 kidney transplants since the inception of its Transplant Program in 1981, placing it among a select group of leading global health centres that have achieved this milestone. Last year alone, KFSHRC has performed 80 [...]
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company submitted the fourth and final module [...]
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® (ustekinumab-ttwe) is approved by FDA for all indications of reference medicine FDA granted provisional determination for interchangeability designation for Pyzchiva® Extends Sandoz immunology portfolio and further strengthens biosimilar position Expected to be among first wave of ustekinumab biosimilars to launch in US [...]
Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 28, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 5,904,962.41 Total number of securities [...]
RIYADH, Saudi Arabia, June 27, 2024 (Korea Bizwire) – King Faisal Specialist Hospital & Research Centre (KFSH&RC) is at the forefront of the global AI and robotics revolution. These technological advancements, driven by Saudi Vision 2030, are set to unlock an estimated $15 billion to $27 billion in economic value for the Kingdom’s medical sector [...]
DURHAM, N.C., June 27, 2024 (Korea Bizwire) – Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI) Innovation Studio, signaling a strategic investment in reshaping the execution of clinical trials today and into the future. The studio will develop and deploy AI and machine learning [...]
Report highlights key progress and achievements across three pillars: access to medicines, R&D innovation, and product quality and patient safety 430,000 patients have been treated with Samsung Bioepis’ biosimilars across 40 countries in 2023 In 10 countries, our biosimilars have created social impact worth approximately 2.5 trillion KRW (1.9 billion USD) in 2023 The company [...]